Investors fled to healthcare stocks for safety. Now insurance and hospital shares are plunging.

By Jaimy Lee

Shares of UnitedHealth, Humana and CVS Health declined this week in light of a new Medicare for All proposal

Hospital and health-insurance stocks fell this week after the government announced plans to crack down on healthcare fraud and Sen. Bernie Sanders revealed a new Medicare for All proposal.

Are healthcare stocks like UnitedHealth Group really the safe bet that investors fleeing the AI trade expect them to be?

That's the big question this week after several health insurance and hospital companies plunged over worries about regulatory threats to their businesses, including a fresh Medicare for All proposal and a government-initiated crackdown on Medicare Advantage health-insurance fraud.

Over the past five days, shares of UnitedHealth (UNH) fell 16.6%, Humana (HUM) dropped 14.2%, and those of CVS Health (CVS) are down 9.1%. The Community Health Systems (CYH) hospital system plunged 26.5%, while Tenet Healthcare (THC) - another large hospital system - is trading about 9.3% lower.

Even Hims & Hers Health (HIMS) fell 19% during a week in which the telehealth company launched a highly anticipated business selling compounded peptides to the American public.

As of Friday morning trading, the State Street Health Care Select Sector SPDR Exchange-Traded Fund XLV declined slightly more this week - 5.8% - than the broader S&P 500 SPX, which is down 5.4%.

At face value, the health-insurance and hospital stocks face serious threats to their businesses.

The shift in power in Washington opened the door to a Democratic healthcare agenda, including a new Medicare for All proposal from Sen. Bernie Sanders, an independent from Vermont, that would lower the age of Medicare eligibility to 55 and add dental, vision and hearing coverage to traditional Medicare. The incremental changes appear more realistic than a full immediate transition to a single-payer health system - and could hurt insurers that already offer Medicare Advantage plans.

But analysts are skeptical that Medicare for All will pan out.

"With no clear Democratic consensus around replacing private insurance, significant legislative hurdles under President [Donald] Trump and no guarantee that the 2028 election produces a more favorable path for Medicare for All, we believe the risk currently reflected in managed care valuations is greater than the probability of the policy ultimately becoming law," wrote Mizuho Securities analyst Ann Hynes in a note.

Industry experts know that issues like this cyclically pop up for healthcare companies, which are heavily regulated by the government, which is also the largest contributor to their revenue. But healthcare policy proposals are often intertwined with politics.

"It's a movie we've seen before and feels all too familiar from the 2019-2020 Democratic primary cycle, when [Medicare for All] concerns peaked as Bernie Sanders and Elizabeth Warren ran for president," Barclays analyst Andrew Mok told investors this week. "While the headline risk is real, the practicality is not."

-Jaimy Lee

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

11-20-26 1053ET

Copyright (c) 2026 Dow Jones & Company, Inc.

The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.

Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.

Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.

Popular

Sponsor Center